Dozee - UnlistedMart

•••• ••••

•••

Key Metrics of Dozee

Market Cap
Total Equity Funding ₹398 Cr in 15 rounds
Latest Funding Round ₹19 Cr, Series A Apr 30, 2026
Post Money Valuation ₹1,440 Cr as on Apr 30, 2026
Annual Revenue ₹19 Cr
▲ 192% YoYas on Mar 31, 2025
EBITDA -₹66 Cr
▼ 3% YoYas on Mar 31, 2025
EBITDA Margin -347.25%
▲ 65% YoYas on Mar 31, 2025
Net Profit ₹74 Cr (Loss)
▼ 8% YoYas on Mar 31, 2025
Net Profit Margin -385.99%
▲ 63% YoYas on Mar 31, 2025

About the Company

Platform offering remote patient monitoring using AI-driven contactless solutions. It provides contactless vital signs monitoring systems and related software. The...

Price on BSE Volume

Funding Rounds

Total Rounds: 15 Dozeehealth.ai

S.No.	Date	Round Name	Amount	TTM Revenue	Investors & Facilitators
1.	Apr 30, 2026	Series A	₹19 Cr	₹33 Cr	Inst: Horizons Ventures
2.	Feb 24, 2026	Series A	₹7.7 Cr	₹33 Cr	Inst: India Accelerator Angel: Tushar, Deepak, Anishkaa
3.	Mar 25, 2025	Conventional Debt	₹65 Cr	₹19 Cr	Inst: Stockhausen International
4.	Feb 13, 2025	Series A	₹15 Cr	₹18 Cr	Inst: C3H Angel: Demis
5.	Oct 30, 2024	Series A	₹59 Cr	₹14 Cr	Inst: Horizons Ventures
6.	Jan 18, 2024	Series A	₹48 Cr	₹6.0 Cr	Inst: The Dietrich Foundation, Prime Venture Partners
7.	Mar 24, 2023	Series A	₹49 Cr	₹3.4 Cr	Inst: J&A Partners, SBI, Prime Venture Partners, 3one4 Capital, YourNest, Aarem Ventures, Dinesh Mody
8.	May 18, 2022	Series A	₹3.7 Cr	₹3.3 Cr	Inst: General Catalyst
9.	May 27, 2021	Series A	₹114 Cr	₹2.7 Cr	Inst: Prime Venture Partners, YourNest, 3one4 Capital, Jain Living Revocable Trust, IndigoEdge Angel: Gokul, Akash
10.	Jul 3, 2020	Seed	₹13 Cr	₹1.2 Cr	Inst: Prime Venture Partners, YourNest, 3one4 Capital, IKP EDEN
11.	Apr 10, 2019	Seed	₹2.7 Cr	₹26.4 Lakh	Inst: IKP EDEN Angel: Saroj Jain, Sumit, Karthik, Sanjeev, Varun, Saurabh, Bart, Nikita, Chitta, Chitta, Naveen, Shantaram, Subrata, Gaurav, Pratyush, Meena, Nithin, Bart, Sanjeev, Saroj
12.	Apr 30, 2018	Seed	₹1.1 Cr	₹33.1 Lakh	Inst: Aarem Ventures, IKP EDEN Angel: Harsha, Yogish, Srhrikant, Sonu, Namita, Srinivas, Priya, Rajamayyoor, Nitesh, Ganesh Nalgunda, Govind, Yogish, Ganesh, Harsha, Nitisha
13.	Aug 29, 2017	Seed	₹50.6 Lakh	₹15.2 Lakh	Inst: IKP EDEN Angel: Vishal, Tarun, Jyotsna, Naveen, Madhu
14.	Nov 30, 2016	Angel	₹43.7 Lakh	-	Angel: Nitesh, Sumit, Satish, Sonu, Nikita, Madhu, Sadanand, Rekha, Manali, Govind, Satish
15.	N/A	Seed	-	-	Angel: Pranav

Financial Statements

Revenue - INR (Cr)

Net Profit/Loss - INR (Cr)

Select a year from the tabs

FY 24-25

FY 23-24

FY 22-23

FY 21-22

FY 20-21

FY 19-20

FY 18-19

FY 17-18

FY 16-17

FY 15-16

Detailed Income Statement

FY 24-25 (in Cr)

19.1

17.4

4.1

13.3

Other income

1.7

92.8

Cost of materials consumed

16.2

Purchases of stock-in-trade

Changes in inventories of finished goods, work-in-progress and stock-in-trade

(12.7)

Employee benefit expense

45.0

Finance costs

2.3

Total depreciation, depletion and amortisation expense

5.0

36.4

Total profit before prior period items, exceptional items, extraordinary items and tax

(73.7)

Exceptional items before tax

Total profit before extraordinary items and tax

(73.7)

Extraordinary items before tax

Total profit before tax

(73.7)

Total profit (loss) for period from continuing operations

(73.7)

Profit (loss) from discontinuing operations before tax

Tax expense of discontinuing operations

Total profit (loss) from discontinuing operation after tax

Profit (loss) of minority interest

Share of profit (loss) of associates

Total profit (loss) for period

(73.7)

Basic earning per equity share before extraordinary items

(0.0)

Diluted earnings per equity share before extraordinary items

(0.0)

Basic earning per equity share

(0.0)

Diluted earnings per equity share

(0.0)

Detailed Balance Sheet

FY 24-25 (in Cr)

118.7

2.2

116.6

69.8

46.8

118.7

25.5

25.1

0.4

Deferred tax assets (net)

Other non-current assets

0.1

92.3

Detailed Cash Flow Statement	FY 24-25 (in Cr)

Detailed Income Statement

FY 23-24 (in Cr)

6.5

5.2

0.0

5.2

Other income

1.3

74.5

Cost of materials consumed

13.2

Purchases of stock-in-trade

Changes in inventories of finished goods, work-in-progress and stock-in-trade

(11.9)

Employee benefit expense

47.0

Finance costs

0.9

Total depreciation, depletion and amortisation expense

2.7

22.4

Total profit before prior period items, exceptional items, extraordinary items and tax

(68.0)

Exceptional items before tax

Total profit before extraordinary items and tax

(68.0)

Extraordinary items before tax

Total profit before tax

(68.0)

Total profit (loss) for period from continuing operations

(68.0)

Profit (loss) from discontinuing operations before tax

Tax expense of discontinuing operations

Total profit (loss) from discontinuing operation after tax

Total profit (loss) for period

(68.0)

Basic earning per equity share before extraordinary items

(0.0)

Diluted earnings per equity share before extraordinary items

(0.0)

Basic earning per equity share

(0.0)

Diluted earnings per equity share

(0.0)

Detailed Balance Sheet

FY 23-24 (in Cr)

105.8

54.0

51.8

17.3

34.5

105.8

10.2

9.8

0.2

Deferred tax assets (net)

Other non-current assets

0.2

95.3

Detailed Cash Flow Statement	FY 23-24 (in Cr)

Detailed Income Statement

FY 22-23 (in Cr)

3.4

2.1

1.0

1.1

Other income

1.3

87.9

Cost of materials consumed

7.1

Purchases of stock-in-trade

Changes in inventories of finished goods, work-in-progress and stock-in-trade

(2.6)

Employee benefit expense

53.3

Finance costs

0.1

Total depreciation, depletion and amortisation expense

0.9

28.6

Total profit before prior period items, exceptional items, extraordinary items and tax

(84.4)

Exceptional items before tax

Total profit before extraordinary items and tax

(84.4)

Extraordinary items before tax

Total profit before tax

(84.4)

Total profit (loss) for period from continuing operations

(84.4)

Profit (loss) from discontinuing operations before tax

Tax expense of discontinuing operations

Total profit (loss) from discontinuing operation after tax

Total profit (loss) for period

(84.4)

Basic earning per equity share before extraordinary items

(0.0)

Diluted earnings per equity share before extraordinary items

(0.0)

Basic earning per equity share

(0.0)

Diluted earnings per equity share

(0.0)

Detailed Balance Sheet

FY 22-23 (in Cr)

78.1

45.8

32.3

21.5

10.8

78.1

4.4

4.2

0.2

Deferred tax assets (net)

Other non-current assets

0.1

73.5

Detailed Cash Flow Statement	FY 22-23 (in Cr)

Detailed Income Statement

FY 21-22 (in Cr)

3.2

1.9

1.3

Other income

0.1

33.9

Cost of materials consumed

5.5

Purchases of stock-in-trade

Changes in inventories of finished goods, work-in-progress and stock-in-trade

(3.7)

Employee benefit expense

17.1

Finance costs

0.1

Total depreciation, depletion and amortisation expense

0.2

14.5

Total profit before prior period items, exceptional items, extraordinary items and tax

(30.7)

Exceptional items before tax

Total profit before extraordinary items and tax

(30.7)

Extraordinary items before tax

Total profit before tax

(30.7)

Total profit (loss) for period from continuing operations

(30.7)

Profit (loss) from discontinuing operations before tax

Tax expense of discontinuing operations

Total profit (loss) from discontinuing operation after tax

Total profit (loss) for period

(30.7)

Basic earning per equity share before extraordinary items

(0.0)

Diluted earnings per equity share before extraordinary items

(0.0)

Basic earning per equity share

(0.0)

Diluted earnings per equity share

(0.0)

Detailed Balance Sheet

FY 21-22 (in Cr)

95.3

87.7

7.6

0.4

7.2

95.3

1.4

1.3

0.0

Deferred tax assets (net)

Other non-current assets

0.1

93.7

Detailed Cash Flow Statement	FY 21-22 (in Cr)

Detailed Income Statement

FY 20-21 (in Cr)

2.6

2.2

1.8

0.5

Other income

0.4

9.4

Cost of materials consumed

Purchases of stock-in-trade

3.3

Changes in inventories of finished goods, work-in-progress and stock-in-trade

(1.7)

Employee benefit expense

3.8

Finance costs

0.1

Total depreciation, depletion and amortisation expense

0.0

3.8

Total profit before prior period items, exceptional items, extraordinary items and tax

(6.7)

Exceptional items before tax

Total profit before extraordinary items and tax

(6.7)

Extraordinary items before tax

Total profit before tax

(6.7)

0.0

Total profit (loss) for period from continuing operations

(6.7)

Profit (loss) from discontinuing operations before tax

Tax expense of discontinuing operations

Total profit (loss) from discontinuing operation after tax

Total profit (loss) for period

(6.7)

Basic earning per equity share before extraordinary items

(0.0)

Diluted earnings per equity share before extraordinary items

(0.0)

Basic earning per equity share

(0.0)

Diluted earnings per equity share

(0.0)

Detailed Balance Sheet

FY 20-21 (in Cr)

6.0

2.7

3.3

0.2

3.2

6.0

0.3

0.2

0.0

Deferred tax assets (net)

Other non-current assets

0.1

5.7

Detailed Cash Flow Statement	FY 20-21 (in Cr)

Detailed Income Statement

FY 19-20 (in Cr)

0.5

0.0

Other income

0.0

4.0

Cost of materials consumed

Purchases of stock-in-trade

0.7

Changes in inventories of finished goods, work-in-progress and stock-in-trade

(0.1)

Employee benefit expense

1.4

Finance costs

0.0

Total depreciation, depletion and amortisation expense

0.0

1.9

Total profit before prior period items, exceptional items, extraordinary items and tax

(3.5)

Exceptional items before tax

Total profit before extraordinary items and tax

(3.5)

Extraordinary items before tax

Total profit before tax

(3.5)

(0.0)

Total profit (loss) for period from continuing operations

(3.5)

Profit (loss) from discontinuing operations before tax

Tax expense of discontinuing operations

Total profit (loss) from discontinuing operation after tax

Total profit (loss) for period

(3.5)

Basic earning per equity share before extraordinary items

(0.0)

Diluted earnings per equity share before extraordinary items

(0.0)

Basic earning per equity share

(0.0)

Diluted earnings per equity share

(0.0)

Detailed Balance Sheet

FY 19-20 (in Cr)

1.1

(4.7)

5.8

4.2

1.5

1.1

0.3

0.2

0.1

Deferred tax assets (net)

0.0

Other non-current assets

0.1

0.8

Detailed Cash Flow Statement	FY 19-20 (in Cr)

Detailed Income Statement

FY 18-19 (in Cr)

0.2

0.0

Other income

0.2

1.2

Cost of materials consumed

Purchases of stock-in-trade

0.4

Changes in inventories of finished goods, work-in-progress and stock-in-trade

(0.2)

Employee benefit expense

0.7

Finance costs

0.0

Total depreciation, depletion and amortisation expense

0.0

0.2

Total profit before prior period items, exceptional items, extraordinary items and tax

(0.9)

Exceptional items before tax

Total profit before extraordinary items and tax

(0.9)

Extraordinary items before tax

Total profit before tax

(0.9)

(0.0)

Total profit (loss) for period from continuing operations

(0.9)

Profit (loss) from discontinuing operations before tax

Tax expense of discontinuing operations

Total profit (loss) from discontinuing operation after tax

Total profit (loss) for period

(0.9)

Basic earning per equity share before extraordinary items

(0.0)

Diluted earnings per equity share before extraordinary items

(0.0)

Basic earning per equity share

(0.0)

Diluted earnings per equity share

(0.0)

Detailed Balance Sheet

FY 18-19 (in Cr)

1.0

(1.2)

2.3

2.1

0.1

1.0

0.1

Deferred tax assets (net)

Other non-current assets

0.9

Detailed Cash Flow Statement	FY 18-19 (in Cr)

Detailed Income Statement

FY 17-18 (in Cr)

0.3

0.1

Other income

0.3

0.9

Cost of materials consumed

0.1

Purchases of stock-in-trade

Changes in inventories of finished goods, work-in-progress and stock-in-trade

Employee benefit expense

0.6

Finance costs

Total depreciation, depletion and amortisation expense

0.0

0.2

Total profit before prior period items, exceptional items, extraordinary items and tax

(0.5)

Exceptional items before tax

Total profit before extraordinary items and tax

(0.5)

Extraordinary items before tax

Total profit before tax

(0.5)

0.0

Total profit (loss) for period from continuing operations

(0.5)

Profit (loss) from discontinuing operations before tax

Tax expense of discontinuing operations

Total profit (loss) from discontinuing operation after tax

Total profit (loss) for period

(0.5)

Basic earning per equity share before extraordinary items

(0.0)

Diluted earnings per equity share before extraordinary items

(0.0)

Basic earning per equity share

(0.0)

Diluted earnings per equity share

(0.0)

Detailed Balance Sheet

FY 17-18 (in Cr)

0.2

(0.3)

0.5

0.4

0.1

0.2

0.1

Deferred tax assets (net)

Other non-current assets

0.1

Detailed Cash Flow Statement	FY 17-18 (in Cr)

Detailed Income Statement

FY 16-17 (in Cr)

0.0

Other income

0.0

0.5

Cost of materials consumed

0.1

Purchases of stock-in-trade

Changes in inventories of finished goods, work-in-progress and stock-in-trade

Employee benefit expense

0.3

Finance costs

Total depreciation, depletion and amortisation expense

0.0

0.1

Total profit before prior period items, exceptional items, extraordinary items and tax

(0.5)

Exceptional items before tax

Total profit before extraordinary items and tax

(0.5)

Extraordinary items before tax

Total profit before tax

(0.5)

0.0

Total profit (loss) for period from continuing operations

(0.5)

Profit (loss) from discontinuing operations before tax

Tax expense of discontinuing operations

Total profit (loss) from discontinuing operation after tax

Total profit (loss) for period

(0.5)

Basic earning per equity share before extraordinary items

(0.0)

Diluted earnings per equity share before extraordinary items

(0.0)

Basic earning per equity share

(0.0)

Diluted earnings per equity share

(0.0)

Detailed Balance Sheet

FY 16-17 (in Cr)

0.2

(0.1)

0.4

0.3

0.1

0.2

0.0

Deferred tax assets (net)

Other non-current assets

0.2

Detailed Cash Flow Statement	FY 16-17 (in Cr)

Detailed Income Statement

FY 15-16 (in Cr)

Other income

0.1

Cost of material consumed

0.1

Purchases of stock in trade

Employee benefit Expense

0.0

Payment to Auditors

0.0

Insurance expenses

Power and fuel

Finance cost

Depreciation and Amortisation expense

0.0

Other expenses

0.0

Profit before exceptional and extraordinary items and tax

(0.1)

Profit before extraordinary items and tax

(0.1)

Profit before tax

(0.1)

0.0

Profit (Loss) for the period from continuing Operations

(0.1)

Profit/ (Loss)

(0.1)

EPS - Basic

0.0

EPS - Diluted

0.0

Detailed Balance Sheet

FY 15-16 (in Cr)

0.0

(0.1)

0.1

0.0

Detailed Cash Flow Statement	FY 15-16 (in Cr)

Shareholding Pattern

As of Apr 30, 2026 • Dozeehealth.ai

Total Shares 0.12M

Top Shareholders

Shareholder	Category	Shares (Mn)	% Holding
Seabright III Limited	Fund	0.03M	22.79%
YourNest India VC Fund II	Fund	0.01M	12.46%
3one4 Capital Fund III	Fund	0.01M	10.68%
Gaurav Parchani	Founder	0.01M	8.62%
Mudit Dandwate	Founder	0.01M	8.62%

Others

Top Competitors

Similar companies to Dozeehealth.ai

Qardio

qardio.com

Circadia

circadia.health

Momo Medical

momomedical.com

Stel

stel.life

Ceras Health

cerashealth.com

Moca Care

mocacare.com

No recent news